Joint Seminar Series | Associate Professor Jake Shortt
A/Professor Jake Shortt Consultant Haematologist | Monash Haematology | Monash Health – Clinical Lead – Leukaemia & Myelodysplasia -Medical Research Future Fund Career Development Fellow.
Title: “Epigenetic therapy for T-cell lymphoma: integrated genomic and clinical analysis of a phase 2 clinical trial”
Associate Professor Jake Shortt is the Head of Haematology Research at the School of Clinical Sciences and clinical lead at Monash Haematology for leukaemia and myelodysplasia. He is Principal Investigator on a range of clinical trials for myeloid malignancies, conducted through the Monash Haematology clinical trials unit. He is also a Principal Investigator on academically-funded and investigator-initiated trials in multiple
myeloma and lymphoma.
Associate Professor Shortt is the recipient of a Medical Research Future Fund Career Development Fellowship as part of the Next Generation Clinical Researchers Program. His strong translational work in the School of Clinical Sciences is focused on strategies incorporating epigenetic drugs with immunotherapy in haematological cancers, particularly lymphoma and multiple myeloma. He heads the Blood Cancer Therapeutics laboratory
within the Monash Health Translation Precinct, facilitating bench-to-bedside research in order to progress these new treatments into the haematology clinic.